Abstract：Objective To investigate the clinical characteristics and treatments of patients with long-term oral aspirin treatment combined with craniocerebral injury.Methods A retrospective analysis was made on 24 cases admitted for long-term oral aspirin treatment combined with craniocerebral injury from January 2010 to June 2012.There were 15 males and 9 females at age of 52-78 years (mean,63.5years).Injuries were caused by a traffic accident in 18 cases,a high fall in four and a blow in two.GCS on admission was 13-15 points in six cases,10-12 points in 10 cases and ＜ 8 points in eight cases.Six cases had conventional treatment,nine puncture drainage,six intracerebral hematoma evacuation by small craniotomy and three hematoma evacuation by large craniotomy.Results The patients were followed up for three months.Glasgow outcome score (GOS) was used to assess the prognosis in five categories,i.e.,grade Ⅴ (good recovery),grade Ⅳ (low disability),grade Ⅲ (severe disability),grade Ⅱ (vegetative state) and grade Ⅰ (death).Besides,grades Ⅴ and Ⅳ GOS represented a good outcome.Of these patients 15 (62.5％) had good results and nine (37.5 ％) undesirable results.Conclusions Patients with long-term oral aspirin administration combined with craniocerebral injury are characterized by high incidence of delayed and progressive cerebral hemorrhage,multi-focus intracerebral hemorrhage and postoperative rehemorrhagia.Therefore,aspirin therapy should be discontinued.Instead,enough blood coagulation accelerator,platelet and fresh plasma should be given.An operation is necessary for the patients with critically severe conditions but is not advisable for the patients with milder conditions.
［1］Antithrobotic Trialilsts’ Collaboration. Collaborative meta-analysis of randommised trials of antiplatelet therapy for prevention of death,myocardial infarction,and stroke in high risk patients. BMJ,2002, 324(7329):71-86.
［2］刘旭.颅脑损伤治疗的进展研究. 中国实用神经疾病杂志,2011,14(17):89-91.
［3］Culebrass A,Rotta-Escalante R, Vila J,et al.Triflusal vs aspirin for prevention of cerebral infarction: a randomized stroke study.Neurology,2004,62(7):1073-1080.
［4］Anderson DC, Goldstein LB. Aspirin: it’s hard to beat. Neurology, 2004, 62(7):1036-1037.
［5］Saloheimo P, Ahonen M, Juvela S, et al. Regular aspirin-use preceding the onset of primary intracerebral hemorrhage is an independent predictor for death. Stroke,2006,37(1):129-133.［6］He J, W helton PK, Vu B, et al. Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. JAMA,1998,280(22):1930-1935.
［7］Roguer J,Rodríguez Campello A,Gomis M,et al.Previous antiplatelet therapy is an independent predictor of 30-day mortality after spontaneous supratentorial intracerebral hemorrhage. J Neuro1,2005,252(4):412-416.
［8］Batchelor JS,Grayson A. A meta-analysis to determine the effect of preinjury antiplatelet agents on mortality in patients with blunt head trauma.Br J Neurosurg,2013,27(1):12-18.
［9］Gum PA,Kottke-Marchant K,Poggio ED,et al.Profile and prevalence of aspirin resistance in patients with cardiovascular disease.Am J Cardiol,2001,88(3):230-235.
［10］Nishijima DK, Zehtabchi S, Berrong J, et al. Utility of platelet transfusion in adult patients with traumatic intracranial hemorrhage and preinjury antiplatelet use:a systematic review. J Trauma Acute Care Surg,2012,72(6):1658-1663.
［12］Moore MM, Pasquale MD, Badellino M. Impact of age and anticoagulation: need for neurosurgical intervention in trauma patients with mild traumatic brain injury. J Trauma Acute Care Surg,2012,73(1):126-130.
［13］Tanber M,Koller H,Moroder P,et al.Secondary hemorrhage after mild head injury in patients with low-dose acetylsalicylate acid prophylaxis.J Trauma,2009,67(3):521-525.
［15］Israelian LA,Lubnin AIu,Tseǐtlin AM.Thromboelastography as a method for preoperative assessment of hemostasis state in neurosurgical patients on long term aspirin therapy.Anesteziol Reanimatol,2011,7(4):27-32.
［16］Moussouttas M.Challenges and controversies in the medical management of primary and antithrombotic-related intracerebral hemorrhage.Ther Adv Neurol Disord,2012,5(1):43-56.
